array:21 [
  "pii" => "X2013251407021069"
  "issn" => "20132514"
  "doi" => " "
  "estado" => "S300"
  "fechaPublicacion" => "2007-04-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2007;27:196-201"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2605
    "formatos" => array:3 [
      "EPUB" => 193
      "HTML" => 1795
      "PDF" => 617
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699507021061"
      "issn" => "02116995"
      "doi" => " "
      "estado" => "S300"
      "fechaPublicacion" => "2007-04-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:196-201"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 5753
        "formatos" => array:3 [
          "EPUB" => 233
          "HTML" => 4839
          "PDF" => 681
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Importancia del líquido de diálisis ultrapuro en la respuesta al tratamiento de la anemia renal con darbepoetina en el paciente en hemodiálisis."
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "196"
            "paginaFinal" => "201"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251407021069"
          "doi" => " "
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021069?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021061?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000002/v0_201502091326/X0211699507021061/v0_201502091326/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407021077"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:202-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2677
      "formatos" => array:3 [
        "EPUB" => 213
        "HTML" => 1874
        "PDF" => 590
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "EVALUATION OF VIRAL LOAD AND ANTIGENEMIA AS MARKERS FOR RELAPSE CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS."
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "202"
          "paginaFinal" => "208"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "ESTUDIO DE CARGA VIRAL Y ANTIGENEMIA COMO VALORES PREDICTIVOS DE RECIDIVA DE INFECCIÓN CMV EN EL TRASPLANTE RENAL"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "ANTONIO FRANCO ESTEVE, RICARDO SERRANO GARCIA, ADELINA GIMENO GASCON, JOAQUIN DE JUAN, ESPERANZA MERINO, LUIS JIMENEZ DEL CERRO, JOAQUIN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "ANTONIO FRANCO ESTEVE, RICARDO SERRANO GARCIA, ADELINA GIMENO GASCON, JOAQUIN DE JUAN, ESPERANZA MERINO, LUIS JIMENEZ DEL CERRO, JOAQUIN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702107X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702107X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021077?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021077/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407021108"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:191-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2535
      "formatos" => array:3 [
        "EPUB" => 209
        "HTML" => 1867
        "PDF" => 459
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "DIALYSATE BACTERIOLOGICAL QUALITY IN A HEALTH DISTRICT"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "191"
          "paginaFinal" => "195"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "CALIDAD BACTERIOLÓGICA DEL DIALIZADO EN UN ÁREA SANITARIA"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "José María Lamas Barreiro Nefrología Hospital Meixoeiro. CHUVI, Mario Alonso Suárez Nefrología Hospital Meixoeiro. CHUVI, Fernándo Sastre Fernández Ne"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "José María Lamas Barreiro Nefrología Hospital Meixoeiro. CHUVI, Mario Alonso Suárez Nefrología Hospital Meixoeiro. CHUVI, Fernándo Sastre Fernández Ne"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507021100"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021100?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021108?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021108/v0_201502091552/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "196"
        "paginaFinal" => "201"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Importancia del líquido de diálisis ultrapuro en la respuesta al tratamiento de la anemia renal con darbepoetina en el paciente en hemodiálisis."
      ]
    ]
    "pdfFichero" => "P-E-S-A4400-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436365"
          "palabras" => array:3 [
            0 => "Líquido dializante ultrapuro"
            1 => "Darbepoetina"
            2 => "Marcadores inflamatorios"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436366"
          "palabras" => array:1 [
            0 => "ultrapure dialysate, darbepoetin, renal anaemia, inflammation"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Chronic inflammatory diseases and infections are a major cause of hyporesponse to erythropoiesis-stimulating factors&#46; We conducted this prospective study in 107 patients in haemodialysis with dialysis liquid that was potentially contaminated from a bacteriological perspective in order to test the hypothesis that ultrapure dialysis liquid can improve the response to treatment with darbepoetin and reduce inflammatory markers&#46; These patients had to have been stable in the last 8 weeks in relation to haemoglobin level and the administered dose of darbepoetin&#46; Two filters &#40;one of hydrophilic nylon and another of polysulfone&#41; were added to the water treatment process&#44; the first one prior to distribution ring output and the second before the dialyser&#46; The patients were evaluated for 12 months&#46; The dosage of darbepoetin was varied to maintain haemoglobin levels ranging from 11 to 14 g&#47;dl&#46; We measured resistance to the erythropoiesis-stimulating factor&#44; defined as the quotient between weekly dose of darbepoetin and haemoglobin levels&#44; baseline and every two months&#44; the baseline and monthly endotoxin count and reactive protein C at baseline and every 6 months&#46; 94 patients completed the study&#46; The resistance index fell significantly during follow-up &#40;p <0 001 and was measurable from the second month on haemoglobin levels remained within established margins with a 34 reduction in weekly dose of darbepoetin at end follow-up period both reactive protein c endotoxin count were significantly reduced p <0 001 compared to baseline after 6 and 12 months conclude the bacteriological purity of dialysis liquid reduces inflammatory markers in patients receiving haemodialysis improving response treatment with darbepoetin renal anaemia</0> </0>"
      ]
      "es" => array:1 [
        "resumen" => "Las enfermedades inflamatorias cr&#243;nicas y las infecciones representan una causa mayor de hiporrespuesta a los factores estimuladores de la eritropoyesis&#46; Para comprobar la hip&#243;tesis de que un l&#237;quido dializante ultrapuro puede mejorar la respuesta al tratamiento con darbepoetina y reducir los marcadores inflamatorios&#44; condujimos este estudio prospectivo&#46; Se reclutaron 107 pacientes en hemodi&#225;lisis con l&#237;quido dializante potencialmente contaminado desde el punto de vista bacteriol&#243;gico&#46; Para ello&#44; deb&#237;an estar estables en las &#250;ltimas 8 semanas en cuanto a niveles de hemoglobina y dosis administrada de darbepoetina&#46; Se a&#241;adieron dos filtros &#40;uno de nylon hidrof&#237;lico y otro de polisulfona&#41; al tratamiento de aguas&#44; el primero previo a la salida al anillo de distribuci&#243;n y el segundo previo al dializador&#46; Los pacientes se evaluaron durante 12 meses&#46; Las variaciones de dosis de darbepoetina se realizaron para mantener niveles de hemoglobina entre 11 y 14 gr&#47;dl&#46; Se determinaron &#237;ndice de resistencia al factor estimulante de la eritropoyesis&#44; definido como el cociente entre dosis semanal de darbepoetina y niveles de hemoglobina&#44; basal y cada 2 meses&#44; el recuento de endotoxinas basal y cada mes&#44; y la proteina C reactiva basal y cada 6 meses&#46; 94 pacientes completaron el estudio&#46; El &#237;ndice de resistencia se redujo de forma significativa durante todo el seguimiento &#40;p <0 001 objetivándose desde el segundo mes los niveles de hemoglobina se mantienen dentro márgenes establecidos con una reducción la dosis darbepoetina semanal un 34 al final del periodo seguimiento p <0 001 tanto la proteina c reactiva como el recuento de endotoxinas se redujeron significativamente p <0 001 frente a las basales los 6 y 12 meses en conclusión la pureza bacteriológica del líquido dializante disminuye marcadores inflamatorios el paciente hemodiálisis así como mejora respuesta al tratamiento con darbepoetina anemia renal</0> </0> </0>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021069/v0_201502091552/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000002/v0_201502091552/X2013251407021069/v0_201502091552/en/P-E-S-A4400-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021069?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis
Importancia del líquido de diálisis ultrapuro en la respuesta al tratamiento de la anemia renal con darbepoetina en el paciente en hemodiálisis.
M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C
Read
5820
Times
was read the article
2400
Total PDF
3420
Total HTML
Share statistics
 array:21 [
  "pii" => "X2013251407021069"
  "issn" => "20132514"
  "doi" => " "
  "estado" => "S300"
  "fechaPublicacion" => "2007-04-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:196-201"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2605
    "formatos" => array:3 [
      "EPUB" => 193
      "HTML" => 1795
      "PDF" => 617
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699507021061"
      "issn" => "02116995"
      "doi" => " "
      "estado" => "S300"
      "fechaPublicacion" => "2007-04-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:196-201"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 5753
        "formatos" => array:3 [
          "EPUB" => 233
          "HTML" => 4839
          "PDF" => 681
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Importancia del l&#237;quido de di&#225;lisis ultrapuro en la respuesta al tratamiento de la anemia renal con darbepoetina en el paciente en hemodi&#225;lisis&#46;"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "196"
            "paginaFinal" => "201"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M MOLINA NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;J&#46; NAVARRO NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;E&#46; PALACIOS NEFROLOG&#205;A NEFROCLUB CARTHAGO&#44; M&#46;C"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "M MOLINA NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;J&#46; NAVARRO NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;E&#46; PALACIOS NEFROLOG&#205;A NEFROCLUB CARTHAGO&#44; M&#46;C"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251407021069"
          "doi" => " "
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021069?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021061?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000002/v0_201502091326/X0211699507021061/v0_201502091326/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407021077"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:202-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2677
      "formatos" => array:3 [
        "EPUB" => 213
        "HTML" => 1874
        "PDF" => 590
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "EVALUATION OF VIRAL LOAD AND ANTIGENEMIA AS MARKERS FOR RELAPSE CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS&#46;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "202"
          "paginaFinal" => "208"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "ESTUDIO DE CARGA VIRAL Y ANTIGENEMIA COMO VALORES PREDICTIVOS DE RECIDIVA DE INFECCI&#211;N CMV EN EL TRASPLANTE RENAL"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "ANTONIO FRANCO ESTEVE&#44; RICARDO SERRANO GARCIA&#44; ADELINA GIMENO GASCON&#44; JOAQUIN DE JUAN&#44; ESPERANZA MERINO&#44; LUIS JIMENEZ DEL CERRO&#44; JOAQUIN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "ANTONIO FRANCO ESTEVE&#44; RICARDO SERRANO GARCIA&#44; ADELINA GIMENO GASCON&#44; JOAQUIN DE JUAN&#44; ESPERANZA MERINO&#44; LUIS JIMENEZ DEL CERRO&#44; JOAQUIN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702107X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702107X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021077?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021077/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407021108"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:191-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2535
      "formatos" => array:3 [
        "EPUB" => 209
        "HTML" => 1867
        "PDF" => 459
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "DIALYSATE BACTERIOLOGICAL QUALITY IN A HEALTH DISTRICT"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "191"
          "paginaFinal" => "195"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "CALIDAD BACTERIOL&#211;GICA DEL DIALIZADO EN UN &#193;REA SANITARIA"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; Mar&#237;a Lamas Barreiro Nefrolog&#237;a Hospital Meixoeiro&#46; CHUVI&#44; Mario Alonso Su&#225;rez Nefrolog&#237;a Hospital Meixoeiro&#46; CHUVI&#44; Fern&#225;ndo Sastre Fern&#225;ndez Ne"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Jos&#233; Mar&#237;a Lamas Barreiro Nefrolog&#237;a Hospital Meixoeiro&#46; CHUVI&#44; Mario Alonso Su&#225;rez Nefrolog&#237;a Hospital Meixoeiro&#46; CHUVI&#44; Fern&#225;ndo Sastre Fern&#225;ndez Ne"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507021100"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021100?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021108?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021108/v0_201502091552/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "196"
        "paginaFinal" => "201"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "M MOLINA NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;J&#46; NAVARRO NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;E&#46; PALACIOS NEFROLOG&#205;A NEFROCLUB CARTHAGO&#44; M&#46;C"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "M MOLINA NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;J&#46; NAVARRO NEFROLOG&#205;A HOSPITAL SANTA MAR&#205;A ROSELL&#44; M&#46;E&#46; PALACIOS NEFROLOG&#205;A NEFROCLUB CARTHAGO&#44; M&#46;C"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Importancia del l&#237;quido de di&#225;lisis ultrapuro en la respuesta al tratamiento de la anemia renal con darbepoetina en el paciente en hemodi&#225;lisis&#46;"
      ]
    ]
    "pdfFichero" => "P-E-S-A4400-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436365"
          "palabras" => array:3 [
            0 => "L&#237;quido dializante ultrapuro"
            1 => "Darbepoetina"
            2 => "Marcadores inflamatorios"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436366"
          "palabras" => array:1 [
            0 => "ultrapure dialysate&#44; darbepoetin&#44; renal anaemia&#44; inflammation"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Chronic inflammatory diseases and infections are a major cause of hyporesponse to erythropoiesis-stimulating factors&#46; We conducted this prospective study in 107 patients in haemodialysis with dialysis liquid that was potentially contaminated from a bacteriological perspective in order to test the hypothesis that ultrapure dialysis liquid can improve the response to treatment with darbepoetin and reduce inflammatory markers&#46; These patients had to have been stable in the last 8 weeks in relation to haemoglobin level and the administered dose of darbepoetin&#46; Two filters &#40;one of hydrophilic nylon and another of polysulfone&#41; were added to the water treatment process&#44; the first one prior to distribution ring output and the second before the dialyser&#46; The patients were evaluated for 12 months&#46; The dosage of darbepoetin was varied to maintain haemoglobin levels ranging from 11 to 14 g&#47;dl&#46; We measured resistance to the erythropoiesis-stimulating factor&#44; defined as the quotient between weekly dose of darbepoetin and haemoglobin levels&#44; baseline and every two months&#44; the baseline and monthly endotoxin count and reactive protein C at baseline and every 6 months&#46; 94 patients completed the study&#46; The resistance index fell significantly during follow-up &#40;p <0 001 and was measurable from the second month on haemoglobin levels remained within established margins with a 34 reduction in weekly dose of darbepoetin at end follow-up period both reactive protein c endotoxin count were significantly reduced p <0 001 compared to baseline after 6 and 12 months conclude the bacteriological purity of dialysis liquid reduces inflammatory markers in patients receiving haemodialysis improving response treatment with darbepoetin renal anaemia</0> </0>"
      ]
      "es" => array:1 [
        "resumen" => "Las enfermedades inflamatorias cr&#243;nicas y las infecciones representan una causa mayor de hiporrespuesta a los factores estimuladores de la eritropoyesis&#46; Para comprobar la hip&#243;tesis de que un l&#237;quido dializante ultrapuro puede mejorar la respuesta al tratamiento con darbepoetina y reducir los marcadores inflamatorios&#44; condujimos este estudio prospectivo&#46; Se reclutaron 107 pacientes en hemodi&#225;lisis con l&#237;quido dializante potencialmente contaminado desde el punto de vista bacteriol&#243;gico&#46; Para ello&#44; deb&#237;an estar estables en las &#250;ltimas 8 semanas en cuanto a niveles de hemoglobina y dosis administrada de darbepoetina&#46; Se a&#241;adieron dos filtros &#40;uno de nylon hidrof&#237;lico y otro de polisulfona&#41; al tratamiento de aguas&#44; el primero previo a la salida al anillo de distribuci&#243;n y el segundo previo al dializador&#46; Los pacientes se evaluaron durante 12 meses&#46; Las variaciones de dosis de darbepoetina se realizaron para mantener niveles de hemoglobina entre 11 y 14 gr&#47;dl&#46; Se determinaron &#237;ndice de resistencia al factor estimulante de la eritropoyesis&#44; definido como el cociente entre dosis semanal de darbepoetina y niveles de hemoglobina&#44; basal y cada 2 meses&#44; el recuento de endotoxinas basal y cada mes&#44; y la proteina C reactiva basal y cada 6 meses&#46; 94 pacientes completaron el estudio&#46; El &#237;ndice de resistencia se redujo de forma significativa durante todo el seguimiento &#40;p <0 001 objetivándose desde el segundo mes los niveles de hemoglobina se mantienen dentro márgenes establecidos con una reducción la dosis darbepoetina semanal un 34 al final del periodo seguimiento p <0 001 tanto la proteina c reactiva como el recuento de endotoxinas se redujeron significativamente p <0 001 frente a las basales los 6 y 12 meses en conclusión la pureza bacteriológica del líquido dializante disminuye marcadores inflamatorios el paciente hemodiálisis así como mejora respuesta al tratamiento con darbepoetina anemia renal</0> </0> </0>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000002/v0_201502091552/X2013251407021069/v0_201502091552/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000002/v0_201502091552/X2013251407021069/v0_201502091552/en/P-E-S-A4400-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021069?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
DOI:
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 3 6 9
2024 October 37 59 96
2024 September 53 61 114
2024 August 52 71 123
2024 July 38 63 101
2024 June 41 44 85
2024 May 36 64 100
2024 April 45 31 76
2024 March 23 28 51
2024 February 26 39 65
2024 January 37 32 69
2023 December 19 33 52
2023 November 32 26 58
2023 October 20 39 59
2023 September 71 43 114
2023 August 29 32 61
2023 July 22 39 61
2023 June 36 27 63
2023 May 33 34 67
2023 April 13 25 38
2023 March 22 10 32
2023 February 17 22 39
2023 January 15 18 33
2022 December 35 27 62
2022 November 20 21 41
2022 October 19 34 53
2022 September 34 13 47
2022 August 34 41 75
2022 July 34 34 68
2022 June 23 29 52
2022 May 27 30 57
2022 April 29 43 72
2022 March 25 39 64
2022 February 30 39 69
2022 January 22 32 54
2021 December 26 40 66
2021 November 32 32 64
2021 October 31 59 90
2021 September 24 38 62
2021 August 25 48 73
2021 July 32 31 63
2021 June 26 21 47
2021 May 18 35 53
2021 April 32 30 62
2021 March 62 37 99
2021 February 24 35 59
2021 January 17 20 37
2020 December 15 25 40
2020 November 19 9 28
2020 October 11 9 20
2020 September 14 10 24
2020 August 27 8 35
2020 July 25 12 37
2020 June 12 6 18
2020 May 41 12 53
2020 April 16 20 36
2020 March 25 9 34
2020 February 32 20 52
2020 January 42 15 57
2019 December 36 14 50
2019 November 23 14 37
2019 October 12 5 17
2019 September 11 12 23
2019 August 11 15 26
2019 July 18 15 33
2019 June 17 9 26
2019 May 19 9 28
2019 April 21 17 38
2019 March 14 9 23
2019 February 5 10 15
2019 January 14 12 26
2018 December 28 38 66
2018 November 20 17 37
2018 October 31 36 67
2018 September 20 21 41
2018 August 17 31 48
2018 July 12 30 42
2018 June 12 15 27
2018 May 17 33 50
2018 April 16 16 32
2018 March 6 19 25
2018 February 6 13 19
2018 January 6 7 13
2017 December 15 10 25
2017 November 16 14 30
2017 October 13 9 22
2017 September 9 8 17
2017 August 19 10 29
2017 July 14 6 20
2017 June 21 5 26
2017 May 13 9 22
2017 April 11 18 29
2017 March 5 8 13
2017 February 10 16 26
2017 January 5 6 11
2016 December 14 5 19
2016 November 12 19 31
2016 October 24 10 34
2016 September 44 5 49
2016 August 101 7 108
2016 July 90 9 99
2016 June 72 0 72
2016 May 97 0 97
2016 April 57 0 57
2016 March 49 0 49
2016 February 74 0 74
2016 January 89 0 89
2015 December 86 0 86
2015 November 73 0 73
2015 October 63 0 63
2015 September 41 0 41
2015 August 58 0 58
2015 July 60 0 60
2015 June 35 0 35
2015 May 52 0 52
2015 April 6 0 6
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?